Bioequivalence and Bioavailability Forum • CFDA: Draft guidance?

CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 05:39 (2137 d 01:14 ago) – Posting: # 18895
Views: 6,125

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Calculate the BE limits for HVDPs based on EMA libaiyi 2018-06-08 11:41 [RSABE / ABEL]
- Calculate the BE limits for HVDPs based on EMA Shuanghe 2018-06-08 12:51
- (Expanded) BE limits, EMA-style Helmut 2018-06-08 13:19
  - (Expanded) BE limits, EMA-style libaiyi 2018-06-11 07:21
    - CFDA: Yet another story? Helmut 2018-06-11 12:24
      - CFDA: Yet another story? libaiyi 2018-06-12 11:09
        
        CFDA: Draft guidance? Helmut 2018-06-12 14:54
        
        CFDA: Draft guidance?libaiyi 2018-06-13 03:39
        
        Hypotheses generated “in face of the data” Helmut 2018-06-13 11:39
        
        Hypotheses generated “in face of the data” libaiyi 2018-06-14 03:46

Admin contact
22,987 posts in 4,824 threads, 1,666 registered users;
81 visitors (0 registered, 81 guests [including 6 identified bots]).
Forum time: 06:53 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity. Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz